BRANDL TALOS advises Sportradar on the Acquisition of InteractSport

Press release • Corporate Law & Transactions from Thomas Talos, Stephan Strass

BRANDL TALOS advised Sportradar Group, a leading global provider of sports data intelligence and sport entertainment solutions, on its acquisition of InteractSport Group, a sports data and technology company based in Australia and England with partnerships across a range of leading sports organisations with a particular expertise in cricket. The acquisition is subject to regulatory approvals and expected to close in Q2/2021.

The acquisition of InteractSport provides Sportradar with the opportunity to expand its portfolio into increasingly popular sports like cricket – being one of the most popular sports in the world with a global fanbase of more than two billion – and include cricket data and content in its offering to the global media and betting markets.

The BRANDL TALOS deal team consisted of Thomas Talos, Stephan Strass, Sonam Schima and Céline Chiara Dobnikar.

McCullough Robertson (Adrian Smith, Alex Hutchens, Andrew Bukowski) advised on aspects of Australian law.



» This is already the third transaction by Sportradar in 2021 in which we supported the Sportradar deal team with our M&A expertise and industry knowledge. We are very pleased that we could once again contribute to a successful acquisition that will position Sportradar as a leading cricket data and content provider. «
Thomas Talos & Stephan Strass
The team
Thomas Talos
Partner / Capital Markets, Corporate Law & Transactions, Gaming & Entertainment
Thomas founded the firm in 2000 together with Ernst Brandl. He is co-publisher of the commentary on the EU Merger Act and (co-)author of numerous publications.

University of Vienna, Faculty of Law (Mag. iur. 1991, Dr. iur. 1994)
University of Virginia, School of Law (LL.M. 1994)
Stephan Strass
Partner / Venture Capital & Start Ups, Corporate Law & Transactions, BioTech & Lifescience
Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)